[(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate

C31H52N2O6 — CID 134984963

IUPAC[(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate
SMILESCC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(C)CCCC(C)C)CC[C@H]4[C@@H]3C[C@@H](N[N+](=O)[O-])[C@@]2(OC(C)=O)C1
InChIInChI=1S/C31H52N2O6/c1-19(2)9-8-10-20(3)25-11-12-26-24-17-28(32-33(36)37)31(39-22(5)35)18-23(38-21(4)34)13-16-30(31,7)27(24)14-15-29(25,26)6/h19-20,23-28,32H,8-18H2,1-7H3/t20?,23-,24-,25+,26-,27-,28+,29+,30+,31-/m0/s1
InChIKeyLOOXPQDQYSGHKL-YUUWERCCSA-N
MW548.77 g/mol
LogP6.48
Rot. Bonds9

About [(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate

[(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate (PubChem CID 134984963) has the molecular formula C31H52N2O6 and a molecular weight of 548.77 g/mol. Its IUPAC name is [(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate.

Molecular Properties

Compound Name[(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate
PubChem CID134984963
Molecular FormulaC31H52N2O6
Molecular Weight548.77 g/mol
Exact Mass548.38
IUPAC Name[(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate
SMILESCC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(C)CCCC(C)C)CC[C@H]4[C@@H]3C[C@@H](N[N+](=O)[O-])[C@@]2(OC(C)=O)C1
InChIInChI=1S/C31H52N2O6/c1-19(2)9-8-10-20(3)25-11-12-26-24-17-28(32-33(36)37)31(39-22(5)35)18-23(38-21(4)34)13-16-30(31,7)27(24)14-15-29(25,26)6/h19-20,23-28,32H,8-18H2,1-7H3/t20?,23-,24-,25+,26-,27-,28+,29+,30+,31-/m0/s1
InChIKeyLOOXPQDQYSGHKL-YUUWERCCSA-N
XLogP6.48
TPSA107.77 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds9
Heavy Atoms39
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500548.77
LogP ≤ 56.48
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'N-nitroso', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-fluoro-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate
CID 134984956
[(3R,5R,6R,8S,9R,10R,13S,14R,17R)-5-chloro-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-6-nitro-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate
CID 125030702
[(1S,2R,5S,7R,9S,11S,12S,15R,16R)-2,16-dimethyl-15-[(2R)-6-methylheptan-2-yl]-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-yl] acetate
CID 10160744
[(2R,15R,16R)-2,16-dimethyl-15-[(2R)-6-methylheptan-2-yl]-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-yl] acetate
CID 54387349
[2,16-dimethyl-15-(6-methylheptan-2-yl)-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-yl] acetate
CID 541303
[(1S,2R,11S,12S,15R,16R)-2,16-dimethyl-15-[(2R)-6-methylheptan-2-yl]-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-yl] acetate
CID 10939191
[(3R,5R,6S,8R,9R,10R,13S,14R,17R)-5-bromo-6-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate
CID 125031686
[(1R,2R,5R,7R,9S,11R,12S,15S,16R)-2,16-dimethyl-15-[(2R)-6-methylheptan-2-yl]-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-yl] acetate
CID 125032120
[(5R,10R,13R)-5-bromo-6-hydroxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate
CID 171036735
[(3S,5R,8R,9R,10R,13R,14S,17S)-5-hydroxy-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate
CID 11890430
[(3R,5R,6R,8R,9S,10R,13S,14S,17R)-5-hydroxy-6-methoxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate
CID 125030949
[(3S,5R,6Z,8R,9R,10R,13R,14R,17R)-5-acetyloxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-6-nitroimino-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
CID 11944700

Frequently Asked Questions

What is the IUPAC name of [(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate?
The IUPAC name of [(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate (CID 134984963) is [(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate.
What is the SMILES notation for [(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate?
The canonical SMILES for [(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate is CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(C)CCCC(C)C)CC[C@H]4[C@@H]3C[C@@H](N[N+](=O)[O-])[C@@]2(OC(C)=O)C1.
What is the InChIKey of [(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate?
The InChIKey is LOOXPQDQYSGHKL-YUUWERCCSA-N. The full InChI is InChI=1S/C31H52N2O6/c1-19(2)9-8-10-20(3)25-11-12-26-24-17-28(32-33(36)37)31(39-22(5)35)18-23(38-21(4)34)13-16-30(31,7)27(24)14-15-29(25,26)6/h19-20,23-28,32H,8-18H2,1-7H3/t20?,23-,24-,25+,26-,27-,28+,29+,30+,31-/m0/s1.
What are the key properties of [(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate?
[(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate has a molecular weight of 548.77 g/mol, XLogP of 6.48, 9 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [(3S,5R,6R,8S,9S,10R,13R,14S,17R)-5-acetyloxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-6-nitramido-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl] acetate is sourced from PubChem (CID 134984963), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).